Pharmaniaga turns in lower earnings


Lodin: ‘Moving forward, the healthcare sector continues to offer good prospects, both in Malaysia and in international markets.’ – Bernama

PETALING JAYA: Pharmaniaga Bhd’s earnings fell 45.7% to RM45.6mil in the financial year ended Dec 31, 2016 as it was impacted by higher operating expenses and finance costs.

The pharmaceutical company said the earnings fell from RM84.04mil in financial year 2015 (FY15).

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

   

Next In Business News

Wall St set to open lower on economic data; Fed verdict on tap
TM to further accelerate AI endeavours this year
Auditor flags going concern for Magna Prima
PTT Synergy buys land for RM36mil
GFIEF to help Malaysia regain positioning as top innovator in Islamic finance
Fernandes: Geopolitical risks will not affect Capital A's regional operations in 2024
Ringgit closes marginally lower against US dollar ahead of Fed meeting
GUH Holdings gets RM69.49mil contract from Gamuda
CIMB Niaga's pre-tax profit rises 7.8% to 2.2 trillion rupiah
F&N profit jumps 63.5% in 2Q on the back of higher revenue

Others Also Read